Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06853990 · ClinicalTrials.gov registry record · NA

Innovative Automated Insulin Delivery System for Type 2 Diabetes

A NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus, sponsored by Deka Research and Development.

Active
Registry status
NA
Development phase
300
Enrollment target
20
Study locations

NCT06853990 is a NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus that is active but no longer recruiting, run by Deka Research and Development. The registered enrollment target is 300 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06853990, a NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by Deka Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.

Conditions Studied

Type 2 Diabetes Insulin Treated Type 2 Diabetes Mellitus

Interventions

  • DEVICE twiist insulin delivery system

Study Locations (20)

California

  • Scripps Whittier Diabetes Institute - La Jolla
  • Hoag Memorial Hospital Presbyterian - Newport Beach
  • Sansum Diabetes Research Institute - Santa Barbara

Massachusetts

  • Massachusetts General Hospital - Boston
  • Boston Medical Center - Boston
  • Joslin Diabetes Center - Boston

Georgia

  • Emory University - Atlanta
  • Endocrine Research Solutions, Inc - Roswell

Michigan

  • University of Michigan - Ann Arbor
  • Henry Ford Health - Detroit

Minnesota

  • International Diabetes Center - Health Partners Institute - Minneapolis
  • Mayo Clinic - Rochester

Colorado

  • University of Colorado - Aurora

Florida

  • University of Miami - Miami

Idaho

  • Rocky Mountain Clinical Research, LLC - Idaho Falls

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-04-14
Est. Completion 2026-06
Phase NA

Sponsor

Deka Research and Development

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06853990

The ClinicalTrials.gov registry entry for NCT06853990 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (73% lower). The listed sponsor is Deka Research and Development, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which twiist insulin delivery system is the first listed.

NCT06853990 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Massachusetts, Georgia.

Frequently Asked Questions

What is clinical trial NCT06853990 about?

NCT06853990 is a clinical study titled "Innovative Automated Insulin Delivery System for Type 2 Diabetes". The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.

What is the current status of trial NCT06853990?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-04-14. Estimated completion is 2026-06.

What conditions does trial NCT06853990 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Insulin Treated Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT06853990?

The interventions under investigation include: twiist insulin delivery system (DEVICE).

Who is sponsoring clinical trial NCT06853990?

This trial is sponsored by Deka Research and Development, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06853990 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Insulin Treated Type 2 Diabetes Mellitus

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.